Delivery Order SPE2DB20D1100-SPE2DB25FC6D7
Award Date 5/30/25
Potential Completion Date 6/2/25
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,156.39 to AmerisourceBergen Drug Corp for MYFEMBREE pharmaceutical products in tablet form (40 mg, 1 mg, and 0.5 mg strengths, 28-count package) with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office...
- The Defense Logistics Agency awarded a delivery order valued at $1,547.13 to AmerisourceBergen Drug Corp for MYFEMBREE 40 MG-1 MG-0.5 MG tablets (28-count), a pharmaceutical product to be delivered to the company's facility in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a non-competitive award under an existing contract vehicle. The award reflects routine pharmaceutical supply procurement...
- The Defense Logistics Agency awarded a delivery order valued at $2,597.46 to AmerisourceBergen Drug Corp for MYFEMBREE pharmaceutical products (40 mg, 1 mg, and 0.5 mg tablets in a 28-count package). This firm fixed-price, non-set-aside contract was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,499.46 to AmerisourceBergen Drug Corp for the supply of Myfembree (40 mg, 1 mg, 0.5 mg tablets, 28-count package) on April 25, 2025, with an ultimate completion date of April 28, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,316.97 to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Myfembree 40 mg, 1 mg, and 0.5 mg tablets in a 28-count package. The contract is a firm fixed price delivery order with no set-aside designation, issued on September 22, 2025, with an ultimate completion date of September 23, 2025. Performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the company's...
- The Defense Logistics Agency awarded a $3,364.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for pharmaceutical products on August 22, 2025, with an ultimate completion date of August 25, 2025. The delivery order covers Myfembree 40 mg–1 mg–0.5 mg tablets in a 28-day supply, a hormonal contraceptive medication. This is a non-set-aside competitive award issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency Troop Support Medical awarded a $1,530.93 delivery order to Amerisourcebergen Drug Corporation for the product "MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S." The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 5-6, 2023. This firm fixed price order was placed under an indefinite-delivery/indefinite-quantity contract vehicle, though details of the underlying contract were not...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Myfembree (40 mg, 1 mg, and 0.5 mg tablets) in a quantity of 28 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,149.77 and is scheduled for completion by September 9, 2025. The contract represents a non-set-aside procurement, indicating AmerisourceBergen's competitive selection among qualified vendors....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,295.88 firm fixed-price delivery order contract is for the pharmaceutical product MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, with an ultimate completion date of October 27, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This is a $1,566.91 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, which has no set-aside designation, is for the supply of the medication MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...